Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial | Synapse
November 15, 2022Open Access
Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial
Key Points
Key points are not available for this paper at this time.
Abstract
UK Joint Global Health Trials Scheme and Canadian Institutes for Health Research Foundation.